... in patients undergoing radical nephroureterectomy followed platinum-based adjuvant chemotherapy. Methods: Pathological samples of 146 UTUC with clinical stage T2 and above undergoing radical nephrectomy (RNU) were collected. All patients received adjuvant cisplatin-based chemotherapy and 40 UTUC patients...

...Jinhyung Jeon; Jae Heon Kim; Jee Soo Ha; Won Jae Yang; Kang Su Cho; Do Kyung Kim Introduction: The objective of this study was to determine effects of adjuvant chemotherapy (AC) on survival outcomes compared to surgery alone without AC for upper tract urothelial carcinoma (UTUC) patients...

... widely accepted than NAC. NAC and AC were generally administered by urologists. Adjuvant chemotherapy Bladder cancer Neoadjuvant chemotherapy Gemcitabine Cisplatin Survey Bladder cancer is the seventh most common cancer in the male population and the 11th most common when considering both...

...Y. Uekado; A. Hirano; T. Shinka; T. Ohkawa Thirty-seven patients who had undergone radical cystectomy and pelvic node dissection for pathologic stage pT2–4 and/or N+ disease received adjuvant chemotherapy involving the injection of cis -platinum alone or in its combination from June 1982 to April...

... to in the content or advertisements. Bladder cancer Chemotherapy Adjuvant chemotherapy Urol Int 1990;45:78-83 © 1990 S. Karger AG, Basel 0 0 4 2 - 1 138/90/0452-0078S2.75/0 Adjuvant Systemic Chemotherapy after Complete Transurethral Resection of Superficially Invasive Bladder Carcinoma (TI G3-4 and T2 G2...